Bulevirtide is a first-in-class entry inhibitor for the treatment of chronic Hepatitis D infection. Bulevirtide prevents Hepatitis D entry into cells. It is effective in the reduction of Hepatitis D virus (HDV) RNA levels and improvement of liver inflammation in cases of Hepatitis D infection. In rats, bulevirtide administered by subcutaneous injection is rapidly absorbed with a Cmax of 4 to 6 hours.
Int J Biol Macromol. 2023 Jun 22;245:125539.
Strongylocentrotus nudus egg polysaccharide (SEP) suppresses HBV replication via activation of TLR4-induced immune pathway
Bulevirtide purchased from AbMole
| CAS Number | 2012558-47-1 |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
[5] D Yardeni, et al. Drugs Today (Barc). Bulevirtide for HBV and HDV infections
[6] Connie Kang, et al. Drugs. Bulevirtide: First Approval
[7] Christopher Koh, et al. Clin Liver Dis. HBV/HDV Coinfection: A Challenge for Therapeutics
| Related Peptides Products |
|---|
| Elcatonin
Elcatonin is a synthetic analog of eel calcitonin that increases bone density and inhibits bone resorption. |
| Pegmolesatide
Pegmolesatide is a synthetic peptide-based erythropoietic agent that may be used in studies related to anemia in chronic kidney disease. |
| Trofinetide
Trofinetide, a water-soluble analog of glycine-proline-glutamic acid (GPE), uses the unnatural amino acid 2-methylproline in place of the proline found in the natural compound, and works by enhancing synaptic activity, restoring synaptic structure, inhibiting the effects of inflammatory compounds in the brain, increasing antioxidant responses, reducing injury-induced cell death, and increasing central IGF-1 presence. It has neuroprotective activity and can be used in studies related to Rett syndrome. |
| Hemopressin (human, mouse)
Hemopressin is a natriuretic peptide derived from the α1 chain of hemoglobin, originally isolated from rat brain homogenates. Hemopressin is also an orally potent, selective inverse agonist at the CB1 cannabinoid receptor.Hemopressin has anti-injury sensory effects in models of inflammatory pain. |
| Trypsin Inhibitor (from Soybean)
Trypsin inhibitor is an alkaline polypeptide consisting of 58 amino acid residues with a pear shape throughout the molecule and a lysine activity center. It can compete with the activity center of many proteases for a lysyl group and inhibit their activities. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
